Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.467
+0.017 (1.17%)
At close: Jun 13, 2025, 4:00 PM
1.489
+0.021 (1.47%)
After-hours: Jun 13, 2025, 7:19 PM EDT
Repare Therapeutics Employees
Repare Therapeutics had 129 employees as of December 31, 2024. The number of employees decreased by 50 or -27.93% compared to the previous year.
Employees
129
Change (1Y)
-50
Growth (1Y)
-27.93%
Revenue / Employee
$8,318
Profits / Employee
-$991,426
Market Cap
62.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
RPTX News
- 4 weeks ago - Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates - Business Wire
- 6 weeks ago - Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics - Business Wire
- 7 weeks ago - Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025 - Business Wire
- 2 months ago - Repare Therapeutics Announces Leadership Transitions - Business Wire
- 3 months ago - Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 5 months ago - Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions - Business Wire